Skip to main content
. 2020 Oct 28;21(21):8010. doi: 10.3390/ijms21218010

Table 1.

Clinical outcome in cancer tissues overexpressing NAA10.

Prognosis Cancer Type Clinical Outcome Reference
Overall Survival Breast cancer Low Wang et al., 2011 [4]
High Kuo et al., 2010 [37]
High Zeng et al., 2014 [51]
Colon cancer Low Jiang et al., 2010 [6]
HCC Low Lee et al., 2018 [19]
Lung cancer Low Lee et al., 2010 [8]
High Hua et al., 2011 [38]
OSCC High Zeng et al., 2016 [46]
Osteosarcoma Low Chien et al., 2018 [5]
Invasiveness HCC MVI Shim et al., 2012 [7]
Metastasis Breast cancer High Wang et al., 2011 [4]
Low Kuo et al., 2010 [37]
Low Zeng et al., 2011 [51]
Lung cancer Low Hua et al., 2011 [38]
OSCC Low Zeng et al., 2016 [46]
Osteosarcoma High Chien et al., 2018 [5]
Recurrence Breast cancer High Wang et al., 2011 [4]
HCC High Lee et al., 2018 [19]
OSCC Low Zeng et al., 2016 [46]

HCC, hepatocellular carcinoma; OSCC, oral squamous carcinoma; MVI, microvascular invasion.